ageas SA/NV (OTCMKTS:AGESY - Get Free Report)'s share price hit a new 52-week high during trading on Tuesday . The company traded as high as $56.19 and last traded at $55.49, with a volume of 3060 shares trading hands. The stock had previously closed at $54.11.
Wall Street Analysts Forecast Growth
Separately, Keefe, Bruyette & Woods cut shares of ageas SA/NV from a "moderate buy" rating to a "hold" rating in a research report on Wednesday, November 13th.
Check Out Our Latest Report on AGESY
ageas SA/NV Trading Down 0.1 %
The firm has a fifty day moving average price of $51.70 and a two-hundred day moving average price of $51.51.
About ageas SA/NV
(
Get Free Report)
ageas SA/NV, together with its subsidiaries, engages in insurance business. It operates in five segments: Belgium, Europe, Asia, Reinsurance, and General Account. The company offers property, casualty, and life insurance products, as well as pension products; and reinsurance products. It provides life insurance products include risks related to the life and death of individuals; and non-life insurance products comprise accident and health, motor, fire, and other property insurance products, as well as insurance services for other damages to property.
Featured Articles
Before you consider ageas SA/NV, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ageas SA/NV wasn't on the list.
While ageas SA/NV currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
